AVUV vs XLV
Avantis US Small Cap Value ETF vs Health Care Select Sector SPDR Fund
- • XLV has the lower expense ratio at 0.08% vs 0.25% for AVUV.
- • XLV pays a higher dividend yield (1.38%).
Side-by-side metrics
| Metric | AVUV | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.25% | 0.08% |
Dividend yield Trailing 12-month yield. | 1.23% | 1.38% |
AUM Assets under management — bigger funds are typically more liquid. | $32.47B | $49.10B |
YTD return | 21.28% | 23.16% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.98 | 0.41 |
P/E ratio | 11.39 | 30.63 |
Last price | $122.88 | $187.94 |
Inception | — | — |
Issuer | Avantis | State Street |
AVUV top holdings
| GATX | GATX Corp | 0.96% |
| MATX | Matson Inc | 0.95% |
| SM | SM Energy Co | 0.85% |
| ANF | Abercrombie & Fitch Co Class A | 0.78% |
| VSAT | Viasat Inc | 0.78% |
| CROX | Crocs Inc | 0.77% |
| M | Macy's Inc | 0.77% |
| LYFT | Lyft Inc Class A | 0.76% |
| MUR | Murphy Oil Corp | 0.74% |
| LEA | Lear Corp | 0.71% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.88% |
| JNJ | Johnson & Johnson | 9.80% |
| ABBV | AbbVie Inc | 7.76% |
| MRK | Merck & Co Inc | 5.49% |
| UNH | UnitedHealth Group Inc | 5.44% |
| TMO | Thermo Fisher Scientific Inc | 3.84% |
| AMGN | Amgen Inc | 3.75% |
| GILD | Gilead Sciences Inc | 3.15% |
| ABT | Abbott Laboratories | 2.74% |
| PFE | Pfizer Inc | 2.59% |
About AVUV
AVUV (Avantis US Small Cap Value ETF) is US small-cap value with profitability screen. Managed by Avantis, the fund carries $32.5B in assets under management, an expense ratio of 0.25%, a dividend yield of 1.23%. Its largest holding is GATX Corp (GATX), which represents 1.0% of the portfolio. Real Estate is the fund's largest sector exposure at 0.6%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $49.1B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.38%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.